Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Burel Pharmaceuticals is a specialty pharmaceutical company based in Mason, Ohio, that focuses on the development and commercialization of niche branded and generic prescription products. The company primarily operates within the dermatology therapeutic area, providing topical treatments for common skin conditions such as acne, rosacea, and seborrheic dermatitis. Burel's portfolio is characterized by specialized formulations, including sodium sulfacetamide and sulfur-based cleansers and creams. By targeting underserved market segments and maintaining a lean operational structure, the company aims to deliver cost-effective and reliable therapeutic options to patients and healthcare providers. Burel Pharmaceuticals remains a private entity with an established commercial presence in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Burel.